Life science investment boosts Oklahoma

Published: Monday, May 6, 2019 By: Scott Meacham Source: NewsOK

At i2E, we like to invest in life sciences companies. About 40 percent of our portfolio is in therapeutics, diagnostics and medical devices. We recognize the abundant opportunity for these types of startups in Oklahoma, and we have developed the staff, expertise and partnerships to commercialize technologies in the sector.

What’s so great about this category of investments? My list is long, but the first and most compelling reason is that startups in life sciences either work or they don’t.

With many early stage companies, investors and entrepreneurs are constantly searching for the right alignment between technology, product and solutions that customers really want. We spend a lot of time and energy trying to figure out and achieve the milestones of a winning path, but the plain truth is that a significant percentage of the time, we end up with a middle-of-the-road outcome where the company doesn’t achieve the results investors and entrepreneurs believed were possible.

Read the full article in The Oklahoman.

Back to top